The Pumpkin Seed Oil Study: A Framework for NP-Led Research & Entrepreneurship
This is a follow-up article to Pumpkin Seed Oil for Hair Loss: An Evidence-Based Guide for Clinicians. In part one, we discussed the prevalence and impact of androgenetic alopecia, commonly known as male- or female- pattern baldness, the underlying pathogenesis, common treatment options, patient dissatisfaction when it comes to side effects, and the growing demand for more complementary and alternative medicines (CAMs). Here, we elaborate on the implications for nursing by discussing solutions that can be implemented and evaluated by DNP and PhD students and graduates, and NP entrepreneurs. This two-part series is part of the introductory curriculum for the Alliance of Cosmetic Nurse Practitioners™ Alopecia Residency, where we transform this knowledge into real-world practice and innovation.
A New Standard for Nursing Research: An Action Plan for Inclusivity
As we identify the gaps in the current research on complementary therapies like pumpkin seed oil, it is not enough to simply call for more studies. As students, nurse leaders, researchers, and entrepreneurs, we have a responsibility to ensure that the future of our research is built on a foundation of equity and inclusivity. When we design our own studies or evaluate others, we must move beyond the status quo and implement concrete solutions.
Here is a framework for ensuring the next generation of nursing research is truly representative and trustworthy.
1. Architect a Representative and Culturally Sensitive Research Team.
Meaningful inclusion starts from within. Before a single participant is recruited, the research team itself should be thoughtfully constructed. This means setting recruitment strategies that aim to build a team reflective of the country's diverse demographics. Furthermore, it is not enough to just have a diverse team; we must equip them. All team members should be highly encouraged to participate in ongoing cultural awareness and sensitivity training to ensure every aspect of the study, from protocol design to patient interaction, is grounded in respect.
References Listed Below
2. Design for Access and Retention.
Historically, clinical trials have placed the burden of participation on the patient. We must reverse this. Our study designs need to proactively implement strategies that overcome common barriers to participation and reduce attrition rates. This could include providing transportation vouchers, offering childcare stipends, utilizing telehealth for follow-up visits to reduce travel, and scheduling appointments outside of standard working hours.
3. Build Trust Through Radical Transparency.
For many communities of color, a history of medical exploitation has created a fragile and well-earned sense of distrust. To rebuild that trust, we must be radically transparent. Every aspect of the study, its objectives, the full details of the research team, and the robust measures in place for participant safety, must be communicated with absolute clarity. This builds a foundation of psychological safety that is a prerequisite for authentic participation. See this article as one example.
4. Collect Comprehensive and Inclusive Data.
To truly understand the impact of any intervention, we must collect data that reflects the full spectrum of our population. This means that the collection of sexual orientation and gender identity (SOGI) data should be a standard, non-negotiable part of our demographic intake.
5. Ensure Linguistic Equity with Technology.
In a country where millions of people speak languages other than English, providing materials only in English is a barrier to access. We must leverage the powerful and now widely accessible AI tools to translate all patient-facing materials, from consent forms and educational handouts to video instructions, into multiple languages, with a particular priority on Spanish (no longer considered a foreign language).
DNP Project Ideas
Quality Improvement (QI) Project
Title: Standardizing Evidence-Based Counseling on Complementary and Alternative Therapies for Androgenetic Alopecia in an Outpatient Dermatology Clinic.
Aim/Purpose: To improve the consistency and evidence-based nature of patient education provided by Nurse Practitioners regarding complementary and alternative medicines (CAMs) for androgenetic alopecia (AGA), specifically focusing on pumpkin seed oil (PSO), thereby enhancing patient understanding and satisfaction.
Description: This project would involve conducting a baseline assessment of current practices and patient knowledge regarding CAMs for AGA. Based on the literature (e.g., PSO efficacy, side effects, and mechanism), a standardized patient education toolkit (including a brief script and a take-home handout) would be developed and implemented. Outcome measures would include NP self-efficacy in counseling, patient satisfaction scores with education received, and patient comprehension of CAM efficacy and safety, aiming for a measurable improvement in these areas over a defined period.
Evidence-Based Practice (EBP) Project
Title: A Pilot Study on the Efficacy of Topical Pumpkin Seed Oil as an Adjunctive Therapy for Female Pattern Hair Loss.
Aim/Purpose: To evaluate the effectiveness and tolerability of topical pumpkin seed oil (PSO) as an adjunctive treatment when combined with standard therapies (e.g., minoxidil) for female pattern hair loss (FPHL) in a clinical setting, leveraging the promising preclinical data.
Description: This project would design a small, randomized, controlled pilot study. Female patients diagnosed with FPHL who are already on a stable regimen of a conventional treatment (e.g., topical minoxidil) would be randomized to receive either an additional topical PSO formulation or a placebo topical for a set duration (e.g., 6 months). Measurements would include hair density and thickness via phototrichography, patient self-assessment of hair growth and satisfaction, and documentation of any adverse events. This project addresses the gap in human topical PSO research, particularly for FPHL, which is less documented than oral PSO for male AGA.
Policy-Focused Initiative
Title: Advocating for Enhanced Regulatory Oversight and Quality Standards for Over-the-Counter Natural Hair Loss Supplements.
Aim/Purpose: To develop and disseminate a policy brief addressing the need for stricter regulatory guidelines and quality control standards for over-the-counter (OTC) natural ingredients marketed for hair loss, such as pumpkin seed oil, to protect consumer safety and ensure product integrity.
Description: This initiative would involve a thorough analysis of the existing regulatory framework for dietary supplements and cosmeceuticals in the context of hair loss treatments, noting that PSO is not FDA-approved as a drug and CAMs generally lack standardization. The project would highlight the importance of product purity (e.g., potential contaminants), accurate labeling, and substantiation of marketing claims. The policy brief would propose concrete recommendations for regulatory bodies (e.g., FDA), professional organizations (e.g., nursing associations), and consumer advocacy groups to improve oversight and foster a market where consumers can make truly informed decisions about natural hair loss products.
Step-by-Step Guide: From Idea to Implementation (for the EBP Project: "A Pilot Study on the Efficacy of Topical Pumpkin Seed Oil as an Adjunctive Therapy for Female Pattern Hair Loss")
Here’s a simple, logical 5-step sequence for implementing the EBP project idea:
Identify the Clinical Problem and Formulate the PICO Question:
Problem: While oral pumpkin seed oil (PSO) shows promise for hair growth in men with androgenetic alopecia (AGA), and topical PSO is effective in mice models, there's limited human evidence on its topical efficacy, especially for female pattern hair loss (FPHL) as an adjunctive therapy. Patients seek natural alternatives due to side effects of conventional treatments.
PICO Question: In adult women with FPHL (P), does the topical application of pumpkin seed oil (I) as an adjunctive therapy to standard minoxidil treatment (C) lead to increased hair density and thickness, and improved patient satisfaction (O) over a 6-month period?
Search for and Appraise the Evidence:
Search Strategy: Utilize databases like PubMed and Google Scholar with keywords such as "pumpkin seed oil," "topical," "hair growth," "female pattern hair loss," "androgenetic alopecia," "minoxidil," and "adjunctive therapy."
Evidence Appraisal: Critically review the identified sources. Note that while oral PSO has strong human evidence for male AGA, and topical PSO has promising results in mice models, direct human clinical trials for topical PSO in FPHL, especially as an adjunct, are scarce in the provided sources. This gap underscores the need for a pilot study. Acknowledge that PSO's mechanism as a 5α-reductase inhibitor and its general safety profile are supported.
Design the Evidence-Based Intervention:
Intervention: Recruit a cohort of adult women with FPHL already on a stable minoxidil regimen. Randomize participants into two groups: one receiving a topical PSO formulation (e.g., 10% PSO, based on mice study) and the other a placebo topical. Both groups continue their standard minoxidil treatment.
Dosage & Frequency: Based on the mice model, a daily topical application for 6 days a week could be considered, or daily, for a period of 24 weeks (6 months) as seen in oral PSO studies.
Outcome Measures: Primary outcomes include change in hair density and hair thickness (measured via phototrichography). Secondary outcomes include patient self-assessment of improvement and satisfaction (using validated scales) and tracking of adverse events.
Implement the Intervention in a Pilot Setting:
Patient Recruitment: Identify eligible female patients in the dermatology clinic who meet inclusion/exclusion criteria. Obtain informed consent, ensuring understanding of the study's pilot nature and use of a non-FDA-approved supplement.
Training & Protocol: Train NPs and research staff on standardized application techniques, phototrichography procedures, and patient follow-up protocols. Ensure double-blinding is maintained where possible (e.g., identical packaging for PSO and placebo).
Data Collection: Conduct baseline assessments. Schedule follow-up visits (e.g., at 3 and 6 months) for repeat hair analyses, self-assessments, and adverse event monitoring, replicating methods from similar studies.
Safety Monitoring: Continuously monitor for and document any side effects or adverse reactions, as seen in previous PSO trials.
Evaluate Outcomes and Disseminate Findings:
Data Analysis: Compare changes in hair density, thickness, and patient satisfaction between the PSO and placebo groups using appropriate statistical analyses. Analyze the incidence and nature of any adverse events.
Interpretation: Determine if topical PSO demonstrates a statistically significant improvement as an adjunctive therapy.
Dissemination: Share findings within the dermatology clinic. Present results at professional conferences and consider submitting for publication in a relevant nursing or dermatological journal.
Future Implications: If the pilot study shows promising results, advocate for larger, multi-center randomized controlled trials to further validate findings and potentially influence clinical guidelines, thus demonstrating the NP's critical role in advancing evidence-based care in dermatologic aesthetics. While you may not have time during NP school, you can continue your work after graduation when you have more time.
PhD Nurse Research Opportunities (Priority gaps & topics):
Based on the limitations and unanswered questions explicitly mentioned across the aforementioned studies, several priority research gaps emerge for future investigation by nurse scientists:
Priority Research Gaps:
Precise Mechanism of Action for Pumpkin Seed Oil (PSO) and Other CAMs: While PSO has shown beneficial effects, the exact mechanism of its action on hair follicles, specifically whether it's solely mediated through 5α-reductase inhibition, an antagonistic effect at androgen receptors, or the contribution of specific components like free fatty acids, phytoestrogens, and vitamin E, remains unclear and requires further investigation.
Long-Term Efficacy and Safety of Complementary and Alternative Medicines (CAMs) for Androgenetic Alopecia (AGA): Existing studies on CAMs for AGA, including PSO, are often of limited duration (e.g., 24 weeks to 6 months), and there is a lack of long-term safety and efficacy data for continuous use beyond one year. The sample sizes in many studies may not be sufficient to identify uncommon or rare adverse events.
Comparative Efficacy of Topical PSO in Human AGA: Although topical PSO showed hair growth promotion in a mice model, making it a "promising alternative", the study cited below was the first report on topical administration of PSO for hair growth. There is a noted absence of human clinical trials specifically evaluating the efficacy of topical PSO, and no comparisons to standard treatments like minoxidil or finasteride have been made for topical PSO. Furthermore, the effect of PSO on frontal AGA, as opposed to vertex AGA, requires discussion in future studies.
Standardization and Bioactive Component Efficacy of CAMs: There is a lack of standardization of bioactive ingredients in many natural remedies, and the literature notes limited scientific evidence and research on their overall efficacy. This ambiguity extends to the functional benefits and potential undesirable side effects of various CAMs.
Efficacy and Safety of CAMs as Monotherapy vs. Adjuvant Therapy: While some CAMs show promise, a lack of head-to-head comparison with standard methods of treatment and a need for further trials to elucidate their efficacy and safety as monotherapy or in combination therapy is highlighted.
Potential PhD Dissertation Topics for a Nurse Scientist:
Investigating the Molecular Pathways and Long-Term Topical Efficacy of Pumpkin Seed Oil in Human Androgenetic Alopecia: A Randomized, Placebo-Controlled Trial. (Addresses gaps in mechanism elucidation, human topical efficacy, and long-term safety/efficacy for PSO specifically).
A Comparative Effectiveness and Patient-Reported Outcomes Study of Topical Pumpkin Seed Oil versus Minoxidil and Combination Therapy for Androgenetic Alopecia over a 12-Month Period. (Addresses gaps in comparative efficacy, long-term outcomes, and patient adherence/satisfaction with different treatment modalities).
Exploring Patient Perspectives, Adherence, and the Impact of Product Standardization on Outcomes in Diverse Populations Utilizing Complementary and Alternative Medicines for Hair Loss. (Addresses gaps in understanding patient-centered outcomes, CAM product consistency, and the need for research in communities of color).
Entrepreneurial Opportunities and Business Strategies:
The latest evidence highlights the significant consumer shift towards natural therapies due to concerns about side effects of conventional treatments and the substantial increase in search interest for agents like pumpkin seed oil (654.4% increase from 2020-2024).
Here are 2-3 innovative strategies an NP entrepreneur could pursue:
Develop an Evidence-Based Digital Education and Product Curation Platform for Hair Loss CAMs:
Concept: Create a premium online platform (e.g., subscription service, course modules) that provides evidence-based education on natural remedies for hair loss, with a strong focus on pumpkin seed oil (PSO) and other well-researched ingredients like rosemary oil and saw palmetto. The platform would synthesize complex research findings into accessible language for both patients and healthcare providers. It would address the noted "limited scientific evidence" and "lack of standardization of their corresponding bioactive ingredients", guiding consumers on how to identify high-quality, transparent products and avoid "misguided" information.
Value Proposition: Offer unbiased reviews, dosage guidance (based on available studies like 400mg/day oral PSO), potential interactions, and realistic expectations. Your authority as an NP and research analyst would lend significant credibility.
Monetization: Subscription tiers for content access, premium modules for in-depth topics, or affiliate partnerships with carefully vetted, transparent supplement brands (with full disclosure).
Launch a Specialized Telehealth Consultation Service for Integrative Hair Loss Management:
Concept: Establish a virtual clinic specializing in integrative hair loss management, offering personalized consultations that combine conventional dermatologic approaches with evidence-informed natural therapies. This service would cater to patients "reluctant to use prescribed medications, or have experienced poor efficacy or side effects", and those seeking "alternative treatments with fewer side effects".
Value Proposition: Doctorally-prepared NPs, your expertise allows for comprehensive assessment, medication management (if desired by the patient), and expert guidance on integrating PSO (given its oral efficacy and promising topical potential) and other CAMs into a personalized regimen. This addresses the "demand for an integrative approach". Services could include detailed dietary analysis (given nutrition's role in hair health), lifestyle modifications, and ongoing monitoring.
Monetization: Fee-for-service consultations, bundled care packages (e.g., 3-month or 6-month programs), and potentially a preferred network for lab testing or compounding pharmacies for specific, evidence-backed topical formulations of PSO or other compounds.
Collaborate on or Develop a "NP-Formulated" Standardized Topical Pumpkin Seed Oil Product Line:
Concept: Given that topical PSO has shown "hair growth promotion" in a mice model and the general interest in topical hair growth supplements, you could partner with a reputable cosmetic chemist or manufacturer to develop a standardized, evidence-based topical PSO product line. This product would address the existing gap in human topical PSO research by ensuring consistent concentrations and purity, and could be positioned as a premium, transparent alternative or adjuvant to conventional treatments.
Value Proposition: The product would be backed by your research analysis, prioritizing ingredients with emerging evidence (like β-sitosterol and linolenic acid from PSO, known for 5α-reductase inhibition) and rigorously tested for safety and efficacy in line with scientific rigor. It would explicitly state its mechanism and supporting evidence, contrasting with often "misguided" market claims.
Monetization: Direct-to-consumer sales, wholesale partnerships with dermatology clinics or med-spas, and leveraging your personal brand for marketing, emphasizing scientific integrity and patient safety.
Conclusion:
Our role extends beyond conventional care; it encompasses integrating cutting-edge, evidence-based solutions into dermatologic practice. The emerging science on natural remedies like pumpkin seed oil for hair loss underscores a critical opportunity to expand our therapeutic toolkit. By meticulously analyzing available research, advocating for rigorous studies, and translating complex findings into actionable patient strategies, we empower individuals to make informed choices. Our commitment to innovation and patient-centered care positions us uniquely to shape the future of hair loss management, ensuring that effective, tolerable, and holistic options are accessible to all.
About the Author
Dr. Kimberly Madison, DNP, AGPCNP-BC, WCC, is a Board-Certified, Doctorally-prepared Nurse Practitioner, educator, and author dedicated to advancing dermatology nursing education and research with an emphasis on skin of color. As the founder of Mahogany Dermatology Nursing | Education | Research™ and the Alliance of Cosmetic Nurse Practitioners™, she expands access to dermatology research, business acumen, and innovation while also leading professional groups and mentoring clinicians. Through her engaging and informative social media content and peer-reviewed research, Dr. Madison empowers nurses and healthcare professionals to excel in dermatology and improve patient care.
.svg)
.svg)
.svg)
.png)
.png)
.png)
.png)
